The human retina serves as a crucial interface for converting light into neural signals and its microvasculature reflects the health of the vascular system. Optical coherence tomography angiography (OCTA) has revolutionized retinal vascular imaging, offering noninvasive, high-resolution visualization. However, challenges persist in the trade-off between the FOV and resolution as well as the low contrast of microvascular, particularly for deeper retinal layers. To address these issues, we developed a complex variance (CV) OCTA system with an ultra-high A-line rate and phase stability based on the phase-locked time-stretch OCT technique. Leveraging a dual-chirped fiber Bragg grating architecture, our system achieves an exceptional 5-MHz A-line rate, sub-nanometer phase stability, and a remarkable 2-mm imaging depth. Our system demonstrated superior spatial resolution compared to commercial OCTA systems, facilitating high-contrast imaging of the foveal avascular zone and deep vascular complex. This technology holds promise for detecting and monitoring retinal and systemic diseases, such as age-related macular degeneration, glaucoma, diabetic retinopathy, and even Alzheimer's disease, thus advancing our understanding of vascular health. This study's findings emphasize the clinical relevance and potential impact of CV OCTA in the field of retinal imaging.